Children's Hospital Boston & Harvard Medical School, MA, USA.
Circulation. 2012 May 1;125(17):2081-91. doi: 10.1161/CIRCULATIONAHA.111.064113. Epub 2012 Mar 28.
Survivors of the Norwood procedure may experience neurodevelopmental impairment. Clinical trials to improve outcomes have focused primarily on methods of vital organ support during cardiopulmonary bypass.
In the Single Ventricle Reconstruction trial of the Norwood procedure with modified Blalock-Taussig shunt versus right-ventricle-to-pulmonary-artery shunt, 14-month neurodevelopmental outcome was assessed by use of the Psychomotor Development Index (PDI) and Mental Development Index (MDI) of the Bayley Scales of Infant Development-II. We used multivariable regression to identify risk factors for adverse outcome. Among 373 transplant-free survivors, 321 (86%) returned at age 14.3 ± 1.1 (mean ± SD) months. Mean PDI (74 ± 19) and MDI (89 ± 18) scores were lower than normative means (each P<0.001). Neither PDI nor MDI score was associated with type of Norwood shunt. Independent predictors of lower PDI score (R(2)=26%) were clinical center (P=0.003), birth weight <2.5 kg (P=0.023), longer Norwood hospitalization (P<0.001), and more complications between Norwood procedure discharge and age 12 months (P<0.001). Independent risk factors for lower MDI score (R(2)=34%) included center (P<0.001), birth weight <2.5 kg (P=0.04), genetic syndrome/anomalies (P=0.04), lower maternal education (P=0.04), longer mechanical ventilation after the Norwood procedure (P<0.001), and more complications after Norwood discharge to age 12 months (P<0.001). We found no significant relationship of PDI or MDI score to perfusion type, other aspects of vital organ support (eg, hematocrit, pH strategy), or cardiac anatomy.
Neurodevelopmental impairment in Norwood survivors is more highly associated with innate patient factors and overall morbidity in the first year than with intraoperative management strategies. Improved outcomes are likely to require interventions that occur outside the operating room.
URL: http://www.clinicaltrials.gov. Unique identifier: NCT00115934.
接受 Norwood 手术的患儿可能存在神经发育损伤。临床试验主要集中在心肺转流期间生命器官支持的方法上,以改善预后。
在接受改良 Blalock-Taussig 分流术与右心室至肺动脉分流术的 Norwood 手术的单心室重建试验中,通过贝利婴幼儿发展量表第二版的精神运动发育指数(PDI)和精神发育指数(MDI)评估 14 个月的神经发育结局。我们使用多变量回归来确定不良结局的危险因素。在 373 例无移植存活者中,321 例(86%)在 14.3±1.1 个月龄时返回。平均 PDI(74±19)和 MDI(89±18)评分均低于正常值(均 P<0.001)。PDI 和 MDI 评分均与 Norwood 分流术类型无关。PDI 评分较低的独立预测因素(R2=26%)为临床中心(P=0.003)、出生体重<2.5kg(P=0.023)、Norwood 住院时间较长(P<0.001)和 Norwood 术后至 12 月龄期间并发症较多(P<0.001)。MDI 评分较低的独立危险因素(R2=34%)包括中心(P<0.001)、出生体重<2.5kg(P=0.04)、遗传综合征/异常(P=0.04)、母亲教育程度较低(P=0.04)、Norwood 术后机械通气时间较长(P<0.001)和 Norwood 出院至 12 月龄期间并发症较多(P<0.001)。我们未发现 PDI 或 MDI 评分与灌注类型、其他生命器官支持方面(如血细胞比容、pH 策略)或心脏解剖结构有显著关系。
Norwood 术后患儿的神经发育损伤与出生时的固有患者因素和第一年的整体发病率的关系更为密切,而与术中管理策略的关系则不太密切。改善预后可能需要在手术室之外进行干预。